Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2024

ESMO-CDDF – Regulatory challenges in clinical cancer drug development

Current status and implications of the In Vitro Diagnostics regulation

Date

16 Sep 2024

Session

ESMO-CDDF – Regulatory challenges in clinical cancer drug development

Topics

Clinical Research

Tumour Site

Presenters

Audrey Wolf

Authors

A. Wolf

Author affiliations

  • EFPIA - European Federation of Pharmaceutical Industries and Associations, 1050 - Brussels/BE

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Q&A and discussion

Session: ESMO-CDDF – Regulatory challenges in clinical cancer drug development

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.